Darnitsa Group

8 february, 2021 22.22
Participation in the global network gives Darnitsa new opportunities for improving professional competencies in context of COVID-19 pandemic, the company remarks.
Darnitsa plans to focus on improving and raising standards for documents preparation, performance of clinical trials, quality assurance and market access of drugs, as well as monitoring of their administration.
1 february, 2021 20.37
There is a global need for vaccines against coronavirus, and the capacities of the companies that produce them are limited; so free access to vaccines will appear when the global needs are met, explained Dmytro Shymkiv, Chairman of the Board of Darnitsa Group.